# ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

> **NCT02910089** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1400 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **BEHAVIORAL:** Shared Decision Making

## Key facts

- **NCT ID:** NCT02910089
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-20
- **Primary completion:** 2017-12-20
- **Final completion:** 2017-12-20
- **Target enrollment:** 1400 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910089, "ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02910089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*